Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diamorphine (heroin) is a semi-synthetic opioid, chemically known as diacetylmorphine, first synthesized in 1874 by acetylating morphine derived from opium poppy latex. Heroin is a prodrug; after administration (by injection, inhalation, or insufflation), it rapidly crosses the blood–brain barrier and is deacetylated to 6-monoacetylmorphine and then to morphine, which binds to μ-opioid receptors to produce analgesic and euphoric effects. Heroin itself is not pharmacologically very active at opioid receptors, but its metabolites, primarily morphine, are. It is highly addictive, with significant risks including respiratory depression, coma, and death. While heroin (diamorphine) may be used in some countries as a prescription analgesic for severe pain, it is most widely known and regulated as a substance of abuse[1][2][3][4][7][9]. The pharmacological target for heroin's effects is the μ-opioid receptor (also called mu-opioid receptor or MOP receptor), which is a G protein-coupled receptor. However, heroin is not the receptor/target; rather, it acts as a ligand (drug) for that target once metabolized to morphine[2][7]. Interacting drugs for heroin (as a substance) include naloxone and naltrexone (opioid receptor antagonists used to counteract overdose), but these interact with opioid receptors, not with heroin as a molecular target[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diamorphine.